Skip to main content

Table 4 Willingness to participate in the four hypothetical protocols if there was a 50% chance of receiving a placebo

From: Attitudes about involvement in hypothetical clinical trial protocols in Mexican and Mexican-American at risk for autosomal dominant Alzheimer’s disease

 

Combined Mexico and U.S. samples (n = 74)

H1: Oral medication trial, 50% placebo

51 (75%)

H2: Vaccine trial, 50% placebo

54 (77%)

H3: Intravenous drug trial, 50% placebo

46 (68%)

H4: Neurosurgery trial, 50% placebo

37 (57%)

  1. H1, H2, H3, and H4, each refers to the four different hypothetical protocols respectively. U.S. United States
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193